Abraxis unveils $70M manufacturing plant in Phoenix

Abraxis Biosciences opened a $70 million facility in Phoenix that will produce Abraxane, a chemotherapy drug for metastatic breast cancer, and other treatments in its pipeline. The manufacturing plant is expected to generate as many as 200 high-tech jobs.

View Full Article in:

Arizona Republic (Phoenix) (tiered subscription model), The · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA